BVS stock · MSFT stock · Lician Pro · $19.99/mo or $149/yr
BVS vs MSFT
Bioventus Inc (BVS) versus Microsoft (MSFT) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) common stock.
Microsoft (MSFT) common stock.
BVS does not have a complete income-statement cache yet.
MSFT does not have a complete income-statement cache yet.
BVS currently screens at market cap $495.1M.
Not investment advice. Open the BVS and MSFT stock pages for the full models.
Basic comparison
Price, market cap, and trailing P/E stay on this page.
| Metric | BVS | MSFT |
|---|---|---|
| Price | $13.30 | — |
| Market cap | $495.1M | — |
| Trailing P/E | — | — |
Deeper peer metrics
Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.
| Metric | BVS | MSFT |
|---|---|---|
| Net income | Pro | Pro |
| Revenue growth | Pro | Pro |
More peer metrics
Operating margin, EPS, free cash flow, and gross margin are on Pro.
BVS vs MSFT comparison FAQ
What is BVS's market cap?
Bioventus Inc (BVS) currently screens at market cap $495.1M.
How many BVS vs MSFT comparison scalars are listed on this page?
This page lists 1 cached comparison scalar for BVS vs MSFT: BVS market cap.
Where is the BVS vs MSFT comparison listed?
The cached BVS vs MSFT comparison is listed at https://lician.com/compare/bvs-vs-msft.
Not investment advice.